American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$276M |
| 2 |
NVIDIA
NVDA
|
+$243M |
| 3 |
Meta Platforms (Facebook)
META
|
+$206M |
| 4 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$165M |
| 5 |
Colgate-Palmolive
CL
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$615M |
| 2 |
Microsoft
MSFT
|
+$544M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$322M |
| 4 |
L3Harris
LHX
|
+$254M |
| 5 |
Idexx Laboratories
IDXX
|
+$227M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.01% |
| 2 | Healthcare | 14.17% |
| 3 | Financials | 13.99% |
| 4 | Consumer Discretionary | 11.07% |
| 5 | Industrials | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Marriott Vacations Worldwide
VAC
$4.17B
| $247K | ﹤0.01% |
1,865
+355
| +24% | +$52.7K |
|
2352
Lincoln Educational Services
LINC
$955M
| $246K | ﹤0.01% |
43,814
-5,549
| -11% | -$33.7K |
|
2353
Kura Oncology
KURA
$896M
| $246K | ﹤0.01% |
20,760
+3,377
| +19% | +$42.1K |
|
2354
Frontline
FRO
$9.02B
| $245K | ﹤0.01% |
15,019
| – | – |
|
2355
Standard Motor Products
SMP
$870M
| $244K | ﹤0.01% |
+6,745
| New | +$257K |
|
|
TWOU
2356
DELISTED
2U Inc
TWOU
| $244K | ﹤0.01% |
+1,186
| New | +$297K |
|
2357
J&J Snack Foods
JJSF
$1.7B
| $239K | ﹤0.01% |
1,633
+245
| +18% | +$35.5K |
|
2358
Freshworks
FRSH
$3.51B
| $239K | ﹤0.01% |
+16,196
| New | +$245K |
|
|
DSKE
2359
DELISTED
Daseke, Inc. Common Stock
DSKE
| $233K | ﹤0.01% |
31,003
+11,402
| +58% | +$83.7K |
|
2360
Clean Energy Fuels
CLNE
$395M
| $232K | ﹤0.01% |
53,264
+8,432
| +19% | +$43.5K |
|
2361
IonQ
IONQ
$18.2B
| $232K | ﹤0.01% |
45,659
+14,779
| +48% | +$69.1K |
|
2362
Workiva
WK
$4.01B
| $230K | ﹤0.01% |
+2,306
| New | +$209K |
|
2363
IDEAYA Biosciences
IDYA
$3.53B
| $230K | ﹤0.01% |
17,023
+5,111
| +43% | +$85.1K |
|
2364
Crawford & Co Class A
CRD.A
$632M
| $229K | ﹤0.01% |
27,515
-5,350
| -16% | -$34.8K |
|
2365
NVE Corp
NVEC
$563M
| $229K | ﹤0.01% |
+2,837
| New | +$212K |
|
|
DCPH
2366
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $229K | ﹤0.01% |
15,215
+3,277
| +27% | +$54.7K |
|
2367
Nature's Sunshine
NATR
$269M
| $228K | ﹤0.01% |
22,304
+675
| +3% | +$6.64K |
|
2368
Theravance Biopharma
TBPH
$878M
| $228K | ﹤0.01% |
21,204
+8,506
| +67% | +$89.9K |
|
|
MRTX
2369
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $227K | ﹤0.01% |
6,199
+286
| +5% | +$12.9K |
|
2370
FuelCell Energy
FCEL
$1.63B
| $227K | ﹤0.01% |
2,726
+204
| +8% | +$20.1K |
|
2371
CNA Financial
CNA
$13.8B
| $227K | ﹤0.01% |
5,824
+1,069
| +22% | +$44.8K |
|
|
CWEN.A
2372
DELISTED
Clearway Energy Class A
CWEN.A
| $227K | ﹤0.01% |
7,650
-1,500
| -16% | -$45.7K |
|
2373
Veracyte
VCYT
$3.42B
| $227K | ﹤0.01% |
10,994
+1,286
| +13% | +$31.1K |
|
|
HSKA
2374
DELISTED
Heska Corp
HSKA
| $226K | ﹤0.01% |
+2,326
| New | +$195K |
|
2375
Resources Connection
RGP
$145M
| $226K | ﹤0.01% |
13,419
+2,781
| +26% | +$48.8K |
|
Similar funds
American Century Companies's Q1 2023 Portfolio in Review
As of Q1 2023, American Century Companies held 2,730 positions worth $127B, up 3.7% from $122B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
American Century Companies's Q1 2023 filing shows 153 new, 1,696 increased, 700 reduced and 63 closed positions. Its largest new stake was Atlassian: 260,346 shares worth $44.6M. The largest sale was Amazon, an estimated $615M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- American Century Companies's largest Q1 2023 buy was Atlassian: 260,346 shares worth $44.6M.
- American Century Companies added most to Humana in Q1 2023, an estimated $276M increase.
- American Century Companies's biggest Q1 2023 reduction was Amazon, cutting an estimated $615M.
- American Century Companies fully exited SVB Financial Group in Q1 2023, selling an estimated $73M.
- American Century Companies's ten largest holdings make up 20% of its $127B portfolio in Q1 2023.
- American Century Companies opened 153 new positions and closed 63 in Q1 2023.
- American Century Companies's portfolio value rose 3.7% quarter-over-quarter to $127B.
Based on American Century Companies's 13F filing for Q1 2023, filed 11 May 2023.